Who is sponsoring NCT03185936?

NCT03185936 is sponsored by Minia University.

What drugs are being tested in NCT03185936?

Interventions in NCT03185936: pars plana vitrectomy with internal limiting membrane (ILM) peeling.

What condition does NCT03185936 study?

NCT03185936 studies Optic Disc Structural Anomaly, Maculopathy.

Is NCT03185936 still recruiting?

NCT03185936 is currently completed. Last updated 14 June 2017.

Last reviewed 2017-06-14 · How we verify

NCT03185936

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Surgical Management of Optic Disc Pit Maculaopathy

Completed NA Last updated 14 June 2017

What this trial tests

NA trial testing pars plana vitrectomy with internal limiting membrane (ILM) peeling in Optic Disc Structural Anomaly in 9 participants. Completed in 1 April 2017.

Timeline

1 March 2011

Primary endpoint
1 April 2016

1 April 2017

Quick facts

Lead sponsor	Minia University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	9
Start date	1 March 2011
Primary completion	1 April 2016
Estimated completion	1 April 2017

Drugs / interventions tested

pars plana vitrectomy with internal limiting membrane (ILM) peeling

Conditions studied

Optic Disc Structural Anomaly — all drugs for Optic Disc Structural Anomaly →
Maculopathy — all drugs for Maculopathy →

Sponsor

Minia University

Who can join

Adults 15 to 75, any sex, with Optic Disc Structural Anomaly or Maculopathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate the anatomical and functional results of pars plana vitrectomy (PPV) combined with internal limiting membrane (ILM) peeling, endolaser photocoagulation and gas tamponade in management of optic disc pit (ODP) maculopathy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Minia University trials

Trials by the same sponsor.

NCT07525687 — Temporary Uterine Tourniquet Application Versus Local Myometrial Epinephrine Injection During Laparoscopic Myomectomy · NA · not yet recruiting
NCT07525674 — Vacuum Sealing Drainage (VSD) in Promoting Wound Healing and Reducing Complications in Post-Infected Obstetric and Gynec · NA · not yet recruiting
NCT07529587 — Laparoscopic Umbilico-uterine Trunk Clipping Approach in the Management of Enhanced Myometrial Vascularity · NA · not yet recruiting
NCT07500558 — Ultrasound Guided Infratemporal Sphenopalatine Ganglion Supravoltage Versus Standard Voltage Pulsed Radiofrequency for P · NA · not yet recruiting
NCT07428057 — Postoperative Hypocalcemia After Thyroidectomy · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03185936 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Minia University
Last refreshed: 14 June 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03185936.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing